Jacobs Levy Equity Management, Inc Biote Corp. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Biote Corp. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 270,475 shares of BTMD stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
270,475
Previous 272,377
0.7%
Holding current value
$1.33 Million
Previous $1.52 Million
11.45%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BTMD
# of Institutions
90Shares Held
18.5MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$22.4 Million12.7% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$12 Million5.9% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$7.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$7.04 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.35MShares$6.65 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $37.3M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...